Relevant Stage 4 Cancer Solutions

  • 236 views
Uploaded on

http://www.envita.com/conditions-we-treat/cancer/stage-4cancer/ - Stage 4 Cancer is also known as Stage IV Cancer, which spread to various sites in the body. It is a complex type of cancer to treat, …

http://www.envita.com/conditions-we-treat/cancer/stage-4cancer/ - Stage 4 Cancer is also known as Stage IV Cancer, which spread to various sites in the body. It is a complex type of cancer to treat, and it can involve many organ systems. Envita’s vast area of technologies options gives stage 4 cancer patients the most complete approach to their cancer.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
236
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Relevant Stage 4 Cancer SolutionsRelevant Stage 4 Cancer SolutionsAs technology and our knowledge base continues to grow, it becomes more important than ever to learnwhat is present in the realm of modern-day cancer treatments – in particular, the availability of newtechniques to deal with advanced and stage 4 cancer. An article on the United States’ websiteHealthReport.gov explains, "Nearly one out of two Americans born today will be diagnosed with cancer atsome point in their lifetime."Moreover, “About 1,596,670 new cancer cases are expected to be diagnosed in 2011 - about 571,950Americans are expected to die of cancer, more than 1,500 people a day – and cancer is the second mostcommon cause of death in the US, exceeded only by heart disease. In the US, cancer alone accounts fornearly 1 of every 4 deaths," reports the *American Cancer Society.Amid these turbulent seas, there is a powerful treatment with which to approach stage 4 cancer calledanti-angiogenic therapy. It works by starving the cancer cells from nutrients, thereby impeding its growthand spread.It is reported that nearly 90 percent of cancer patients succumb when their cancer metastasizes – thecalling card of stage 4 cancer. Angiogenesis is the process by which tumors grow by attracting bloodvessels to “nourish” themselves. However, a technique exists to thwart these very processes. Withnewly developed modern “alternative” medicines, both metastasis and angiogenesis can be impeded oreven subjugated. Envita leads the domestic pack by currently offering such integrative and unique processes. There is nodenying that patients benefit from an anti-angiogenic approach to supplement most traditionalchemotherapy regimes. Through rigorous tests and analysis, Envita recommends and implements
  • 2. strategies that will work synergistically with the body to enhance the ultimate goal of patient health andwell-being.With these great developments, it is important to give credit where credit is due. The origin of thisresearch field began with Judah Folkman, who realized that a tumor placed in a lab container had only alimited potential for growth, establishing that its micro vascular network was being disrupted.In the early days of his papers, 1964 to 1989, his findings were largely overlooked by many. While theyagreed that there was evidence of newly forming vessels, the assumption was that the smaller, weakercell networks were merely a side effect associated with the dying tumor cells. Eventually, Folkman couldprove that the new vessels were actually being fashioned by the cancer cells themselves as a means ofsupplemental nourishment.In hindsight, it is something of an embarrassment that Dr. Folkman was treated the way he was in theearly days of his findings. In an industry so overcome by a poor track-record, one would think thatinnovators, free thinkers, and pioneers would be eagerly welcomed to the table. Unfortunately, cancerresearch, like so many other fields, seems to harbor the same common pattern of contempt for the newand unknown.Another such example of this contemptuous foolery came when Don Ingber found that a funguscontaminated some of his endothelial cell test samples, which caused their growth to cease. Of course,Inber was ignored and treated like a quack, until later it was proven that angiogenesis could, in fact, beinhibited.Today, anti-angiogenic drugs such as sorafenib (Nexavar®), sunitinib (Sutent®), pazopanib (Votrient®),and everolimus (Afinitor®) are typically prescribed in late-stage cancers in order to impeded growth. Thatbeing said, a simple agent like oxygen (not patentable) is an oft overlooked. To put it mildly, oxygen isnothing less than a dominant anti-angiogenic agent. Oxygen becomes an important agent for stage 4cancer treatment.In fact, errors occurring in oxygen metabolism are often at the root of cancer causes as well as theircontinued development. Moreover, understanding the role of oxygen and correctly administering it canbe vital for success in stage 4 cancer cases.It is no secret that cancer cells rely upon a blood supply to spread. So, it stands to reason thatangiogenesis should be blocked to stop tumor growth. Virtually, all tumors demand an unending supply ofnutrients supplied via blood to continue to spread. Without such supplies, tumor growth is limited to amanageable 2 mm.In stage 4 cancer cases, it is a lack of oxygen that ultimately feeds growth and spread. The introduction ofvascular endothelial growth factor (VEGF) to angiogenesis, a critical process, actually occurs because ofhypoxia – the absence of oxygen. Transcriptional factor HIF-1 (hypoxia inducible factor 1) allows thisprocess to materialize.There is always a need for hypoxic tissue on tumors to promote the release of VEGF - as they invariablyaim to grow beyond the limits of the blood supply. Should we dedicate one chemotherapy treatment toblock VEGF, we could then target ways to improve the tumor’s oxygen metabolism.
  • 3. Tumors cannot grow or spread without VEGF. By enhancing the body’s ability to carry oxygen andemploying other cancer-killing methods simultaneously, Envita is creating new approaches to eliminatecancer and the processes that allow for their development and growth. One secret is the ability to createan environment that is unwelcome to stage 4 cancer cells.And there is more good news, now that we know that precarious blood cells are an excellent way to targetcancers. Released VEGF binds to the endothelial cells of nearby vessels, and subsequently, they beginto break up and grow in the direction of the tumor in an effort to bring new vessels to feed it. Theseinferior vessels are relatively easy to detect through photodynamic protocols, which means they can beisolated and attacked while simultaneously strengthening healthy vessels throughout the body.Research shows that VEGF is connected with a series of tumor types, including breast, ovarian, cervical,esophageal, lung, and cervical cancer, as well as glioblastoma multiforme and renal cell carcinoma. Itwould seem that VEGF emissions may also hinder the immune system’s ability to react and fight off thetumor - regularly occurring in stage 4 cancers.One thing to keep in mind is that the immune system is the first and last defense against stage 4 cancer.More than 90 percent of all cancer patients die because of metastasis, a critical component for stage 4cancer – the very process by which cancer cells can spread into the blood supply and be dispersedthroughout the body. Sadly, many patients believe their cancer had been eradicated, only to discoverlater about dormant metastasis and why cancer comes back often at stage 4. For this reason, it isimperative to correct the body’s metabolism for oxygen and put a stop to angiogenesis.For more information and articles on stage 4 cancer treatments, contact or visit us at Envita’s website. Ifyou know anyone who has been diagnosed with cancer, please forward this article to them. We welcomeyou to contact us with questions and invite you to watch informative videos. You can also visit our PPMRsection to learn more about the power of Envita’s personalized medicine (link to Envita PPMR page)for stage 4 cancer (link Envita cancer page) and chronic diseases. It is important information that maysave lives. Education is the best prescription.Envita’s Comprehensive Smart Oncology uses the foremost of oncology in combination with aggressivenatural therapies to help a patient reach better health.References:*Judah Folkman <http://www.pbs.org/wgbh/nova/body/cancer-warrior.html > , <http://en.wikipedia.org/wiki/Judah_Folkman > *Stage 4 Cancer < http://en.wikipedia.org/wiki/Stage-4_cancer#Systems_of_staging > * Vascular endothelial growth factor<http://en.wikipedia.org/wiki/Vascular_endothelial_growth_factor>*HealthReform.gov<http://www.healthreform.gov/reports/fightingcancer/index.html>*American Cancer Society<http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf>